An integrated microfluidic system for screening of phage-displayed peptides specific to colon cancer cells and colon cancer stem cells

Yu Jui Che, Huei Wen Wu, Lien Yu Hung, Ching Ann Liu, Hwan You Chang, Kuan Wang, Gwo Bin Lee

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Affinity reagents recognizing biomarkers specifically are essential components of clinical diagnostics and target therapeutics. However, conventional methods for screening of these reagents often have drawbacks such as large reagent consumption, the labor-intensive or time-consuming procedures, and the involvement of bulky or expensive equipment. Alternatively, microfluidic platforms could potentially automate the screening process within a shorter period of time and reduce reagent and sample consumption dramatically. It has been demonstrated recently that a subpopulation of tumor cells known as cancer stem cells possess high drug resistance and proliferation potential and are regarded as the main cause of metastasis. Therefore, a peptide that recognizes cancer stem cells and differentiates them from other cancer cells will be extremely useful in early diagnosis and target therapy. This study utilized M13 phage display technology to identify peptides that bind, respectively, to colon cancer cells and colon cancer stem cells using an integrated microfluidic system. In addition to positive selection, a negative selection process was integrated on the chip to achieve the selection of peptides of high affinity and specificity. We successfully screened three peptides specific to colon cancer cells and colon cancer stem cells, namely, HOLC-1, HOLC-2, and COLC-1, respectively, and their specificity was measured by the capture rate between target, control, and other cell lines. The capture rates are 43.40 ± 7.23%, 45.16 ± 7.12%, and 49.79 ± 5.34% for colon cancer cells and colon cancer stem cells, respectively, showing a higher specificity on target cells than on control and other cell lines. The developed technique may be promising for early diagnosis of cancer cells and target therapeutics.

Original languageEnglish
Article number054121
JournalBiomicrofluidics
Volume9
Issue number5
DOIs
Publication statusPublished - Jan 1 2015
Externally publishedYes

Fingerprint

Bacteriophages
Microfluidics
Neoplastic Stem Cells
stem cells
Stem cells
Colonic Neoplasms
Peptides
peptides
Screening
screening
cancer
Cells
reagents
cultured cells
affinity
Bacteriophage M13
Cell Line
Biomarkers
labor
biomarkers

ASJC Scopus subject areas

  • Molecular Biology
  • Materials Science(all)
  • Genetics
  • Condensed Matter Physics
  • Physical and Theoretical Chemistry

Cite this

An integrated microfluidic system for screening of phage-displayed peptides specific to colon cancer cells and colon cancer stem cells. / Che, Yu Jui; Wu, Huei Wen; Hung, Lien Yu; Liu, Ching Ann; Chang, Hwan You; Wang, Kuan; Lee, Gwo Bin.

In: Biomicrofluidics, Vol. 9, No. 5, 054121, 01.01.2015.

Research output: Contribution to journalArticle

Che, Yu Jui ; Wu, Huei Wen ; Hung, Lien Yu ; Liu, Ching Ann ; Chang, Hwan You ; Wang, Kuan ; Lee, Gwo Bin. / An integrated microfluidic system for screening of phage-displayed peptides specific to colon cancer cells and colon cancer stem cells. In: Biomicrofluidics. 2015 ; Vol. 9, No. 5.
@article{6f3039d5d4f84699a4fe122e6f47ec7c,
title = "An integrated microfluidic system for screening of phage-displayed peptides specific to colon cancer cells and colon cancer stem cells",
abstract = "Affinity reagents recognizing biomarkers specifically are essential components of clinical diagnostics and target therapeutics. However, conventional methods for screening of these reagents often have drawbacks such as large reagent consumption, the labor-intensive or time-consuming procedures, and the involvement of bulky or expensive equipment. Alternatively, microfluidic platforms could potentially automate the screening process within a shorter period of time and reduce reagent and sample consumption dramatically. It has been demonstrated recently that a subpopulation of tumor cells known as cancer stem cells possess high drug resistance and proliferation potential and are regarded as the main cause of metastasis. Therefore, a peptide that recognizes cancer stem cells and differentiates them from other cancer cells will be extremely useful in early diagnosis and target therapy. This study utilized M13 phage display technology to identify peptides that bind, respectively, to colon cancer cells and colon cancer stem cells using an integrated microfluidic system. In addition to positive selection, a negative selection process was integrated on the chip to achieve the selection of peptides of high affinity and specificity. We successfully screened three peptides specific to colon cancer cells and colon cancer stem cells, namely, HOLC-1, HOLC-2, and COLC-1, respectively, and their specificity was measured by the capture rate between target, control, and other cell lines. The capture rates are 43.40 ± 7.23{\%}, 45.16 ± 7.12{\%}, and 49.79 ± 5.34{\%} for colon cancer cells and colon cancer stem cells, respectively, showing a higher specificity on target cells than on control and other cell lines. The developed technique may be promising for early diagnosis of cancer cells and target therapeutics.",
author = "Che, {Yu Jui} and Wu, {Huei Wen} and Hung, {Lien Yu} and Liu, {Ching Ann} and Chang, {Hwan You} and Kuan Wang and Lee, {Gwo Bin}",
year = "2015",
month = "1",
day = "1",
doi = "10.1063/1.4933067",
language = "English",
volume = "9",
journal = "Biomicrofluidics",
issn = "1932-1058",
publisher = "American Institute of Physics",
number = "5",

}

TY - JOUR

T1 - An integrated microfluidic system for screening of phage-displayed peptides specific to colon cancer cells and colon cancer stem cells

AU - Che, Yu Jui

AU - Wu, Huei Wen

AU - Hung, Lien Yu

AU - Liu, Ching Ann

AU - Chang, Hwan You

AU - Wang, Kuan

AU - Lee, Gwo Bin

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Affinity reagents recognizing biomarkers specifically are essential components of clinical diagnostics and target therapeutics. However, conventional methods for screening of these reagents often have drawbacks such as large reagent consumption, the labor-intensive or time-consuming procedures, and the involvement of bulky or expensive equipment. Alternatively, microfluidic platforms could potentially automate the screening process within a shorter period of time and reduce reagent and sample consumption dramatically. It has been demonstrated recently that a subpopulation of tumor cells known as cancer stem cells possess high drug resistance and proliferation potential and are regarded as the main cause of metastasis. Therefore, a peptide that recognizes cancer stem cells and differentiates them from other cancer cells will be extremely useful in early diagnosis and target therapy. This study utilized M13 phage display technology to identify peptides that bind, respectively, to colon cancer cells and colon cancer stem cells using an integrated microfluidic system. In addition to positive selection, a negative selection process was integrated on the chip to achieve the selection of peptides of high affinity and specificity. We successfully screened three peptides specific to colon cancer cells and colon cancer stem cells, namely, HOLC-1, HOLC-2, and COLC-1, respectively, and their specificity was measured by the capture rate between target, control, and other cell lines. The capture rates are 43.40 ± 7.23%, 45.16 ± 7.12%, and 49.79 ± 5.34% for colon cancer cells and colon cancer stem cells, respectively, showing a higher specificity on target cells than on control and other cell lines. The developed technique may be promising for early diagnosis of cancer cells and target therapeutics.

AB - Affinity reagents recognizing biomarkers specifically are essential components of clinical diagnostics and target therapeutics. However, conventional methods for screening of these reagents often have drawbacks such as large reagent consumption, the labor-intensive or time-consuming procedures, and the involvement of bulky or expensive equipment. Alternatively, microfluidic platforms could potentially automate the screening process within a shorter period of time and reduce reagent and sample consumption dramatically. It has been demonstrated recently that a subpopulation of tumor cells known as cancer stem cells possess high drug resistance and proliferation potential and are regarded as the main cause of metastasis. Therefore, a peptide that recognizes cancer stem cells and differentiates them from other cancer cells will be extremely useful in early diagnosis and target therapy. This study utilized M13 phage display technology to identify peptides that bind, respectively, to colon cancer cells and colon cancer stem cells using an integrated microfluidic system. In addition to positive selection, a negative selection process was integrated on the chip to achieve the selection of peptides of high affinity and specificity. We successfully screened three peptides specific to colon cancer cells and colon cancer stem cells, namely, HOLC-1, HOLC-2, and COLC-1, respectively, and their specificity was measured by the capture rate between target, control, and other cell lines. The capture rates are 43.40 ± 7.23%, 45.16 ± 7.12%, and 49.79 ± 5.34% for colon cancer cells and colon cancer stem cells, respectively, showing a higher specificity on target cells than on control and other cell lines. The developed technique may be promising for early diagnosis of cancer cells and target therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=84945161880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945161880&partnerID=8YFLogxK

U2 - 10.1063/1.4933067

DO - 10.1063/1.4933067

M3 - Article

AN - SCOPUS:84945161880

VL - 9

JO - Biomicrofluidics

JF - Biomicrofluidics

SN - 1932-1058

IS - 5

M1 - 054121

ER -